Generate Biomedicines, Inc.
GENB CIK: 0002100782
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
State of Incorporation DE
Business Address 101 SOUTH STREET, SUITE 900, SOMERVILLE, MA, 02143
Mailing Address 101 SOUTH STREET, SUITE 900, SOMERVILLE, MA, 02143
Phone 888-469-0055
Fiscal Year End 1231
EIN 831630228
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | February 13, 2026 | View on SEC |
| S-1 IPO registration statement | February 4, 2026 | View on SEC |
IPO Filings
S-1 February 4, 2026
- Pioneering AI-powered platform for de novo drug design, aiming to accelerate and improve drug discovery.
- Advanced three AI-designed drugs into human clinical testing, including one in late-stage (Phase 3) trials for severe asthma.
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.